Nu Skin Enterprises (NUS, NYSE) traded higher on an improved sales and profit outlook. Including a restructuring charge, December-quarter earnings per share are now expected to range from $0.37 to $0.39, versus a prior view of $0.32 to $0.34. Revenue should be $360 million to $365 million, up from previous guidance of $343 million to $348 million. For full-year 2010, management forecasts per-share earnings of $1.60 to $1.70, compared to the consensus of $1.62. Nu Skin, which distributes premium personal-care products, is benefiting from a successful launch of its new anti-aging products. Nu Skin is ranked Buy.
Richard Moroney, Upside
